Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline
1994

Pentoxifylline Improves Tumor Blood Flow and Oxygenation

Sample size: 19 publication Evidence: moderate

Author Information

Author(s): I. Lee, Y. Boucher, T.J. Demhartner, R.K. Jain

Primary Institution: Massachusetts General Hospital, Harvard Medical School

Hypothesis

Pentoxifylline improves tumor perfusion, leading to increased oxygen supply and decreased interstitial fluid pressure.

Conclusion

Pentoxifylline at 100 mg/kg significantly increases oxygen availability in tumors and lowers interstitial fluid pressure without affecting mean arterial blood pressure.

Supporting Evidence

  • Pentoxifylline at 100 mg/kg increased median P02 from 5 to 7 mmHg.
  • RBC flux in the tumor center increased significantly after PTX treatment.
  • Interstitial fluid pressure decreased by approximately 40% after PTX administration.

Takeaway

Pentoxifylline helps tumors get more oxygen and reduces pressure inside them, which can make cancer treatments work better.

Methodology

The study measured P02, RBC flux, and interstitial fluid pressure in FSaII murine tumors after administering pentoxifylline at two doses.

Limitations

The study only tested two doses of pentoxifylline and focused on a specific tumor type.

Participant Demographics

Female C3Hf/Sed mice, 8-10 weeks of age.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication